OpenURL Connection Search

Select item for more details and to access through your institution.

Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary.
Published in:
Clinical & Experimental Gastroenterology, 2019, v. 12, p. 93, doi. 10.2147/CEG.S184016
By:
- Fehnel, Sheri;
- Fiedorek, Fred T;
- Nelson, Lauren;
- DiBenedetti, Dana;
- Spence, Sharon;
- Carson, Robyn T
Publication type:
Article
Coadministration of muraglitazar plus glyburide: Improvement of glycaemic and lipid profiles in patients with type 2 diabetes.
Published in:
Diabetes & Vascular Disease Research, 2009, v. 6, n. 2, p. 120, doi. 10.1177/1479164109336049
By:
- Rubin, Cindy J.;
- De Pril, Veerle;
- Fiedorek, Fred T.
Publication type:
Article
Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes.
Published in:
Diabetes & Vascular Disease Research, 2009, v. 6, n. 3, p. 205, doi. 10.1177/1479164109336048
By:
- Rubin, Cindy J.;
- Viraswami-Appanna, Kalyanee;
- Fiedorek, Fred T.
Publication type:
Article
Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride.
Published in:
Diabetes & Vascular Disease Research, 2008, v. 5, n. 3, p. 168, doi. 10.3132/dvdr.2008.028
By:
- Rubin, Cindy J;
- Ledeine, Jean-Marie;
- Fiedorek, Fred T
Publication type:
Article
Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator-Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
Published in:
Diabetes Care, 2006, v. 29, n. 5, p. 1016, doi. 10.2337/dc05-1146
By:
- Kendall, David M.;
- Rubin, Cindy J.;
- Mohideen, Pharis;
- Ledeine, Jean-Marie;
- Belder, Rene;
- Gross, Jorge;
- Norwood, Paul;
- O'Mahony, Michael;
- Sall, Kenneth;
- Sloan, Greg;
- Roberts, Anthony;
- Fiedorek, Fred T.;
- DeFronzo, Ralph A.
Publication type:
Article
A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.
Published in:
2009
By:
- Wilding JP;
- Norwood P;
- T'joen C;
- Bastien A;
- List JF;
- Fiedorek FT;
- Wilding, John P H;
- Norwood, Paul;
- T'joen, Caroline;
- Bastien, Arnaud;
- List, James F;
- Fiedorek, Fred T
Publication type:
journal article
A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers.
Published in:
Diabetes Care, 2009, v. 32, n. 9, p. 1656, doi. 10.2337/dc09-0517
By:
- Wilding, John P.H.;
- Norwood, Paul;
- T'Joen, Caroline;
- Bastien, Arnaud;
- List, James F.;
- Fiedorek, Fred T.
Publication type:
Article
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes.
Published in:
Diabetes Care, 2009, v. 32, n. 4, p. 650, doi. 10.2337/dc08-1863
By:
- List, James F.;
- Woo, Vincent;
- Morales, Enrique;
- Tang, Weihua;
- Fiedorek, Fred T.
Publication type:
Article

Found: 8